BUY SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS

Similar documents
Perpetual (PPT) Oversold, upgrade to Buy. Over 6% yield, with upside in market rally. Quarterly highlights. Earnings revisions

Platinum Asset Management (PTM)

Adacel Technologies (ADA)

Praemium (PPS) COMPANY REPORT. Model performance

BWX Limited (BWX) SOURCE: BELL POTTER SECURITIES ESTIMATES

Consolidated Operations Group (COG)

Nanosonics (NAN) Preparing for new international markets. Maintain Hold, price target amended to $3.20 SOURCE: BELL POTTER SECURITIES ESTIMATES

OneVue Holdings (OVH)

Cash Converters Intl.

Praemium (PPS) COMPANY REPORT. Quartermaster

OneVue Holdings (OVH)

Sunway Unlocking value in construction

Wisr Ltd (DirectMoney)

Insurance Brokers SECTOR REPORT. Solid Hold. -4% Jun-12. Dec-12. Mar-13. Sep-13. Sep-12. Jun-13. Source: APRA, Baillieu Holst estimates

Wisr Ltd (DirectMoney)

WINDLAB LTD HOLD. Lakeland financial close delayed again. Downgrade to HOLD. COMPANY UPDATE EVENT IMPACT INVESTMENT VIEW

UBS Investment Research Brambles Limited

MEDICAL DEVELOPMENTS INTERNATIONAL LTD

Aged Care. Propco sale & lease back A$2.71 A$5.75 A$6.15 AUSTRALIA. Event. Impact. Outlook

Stock Focus. Pioneer Credit (PNC) Tuesday, 12 April 2016

Regional Express Holdings Ltd REX

PRICE $1.30 Regional Express Holdings Ltd REX

COMPUMEDICS LTD HOLD. CMP Downgrades FY17 Guidance COMPANY UPDATE EVENT KEY TAKE-AWAYS INVESTMENT VIEW

BUY DCN SHARE PRICE FORECAST PRODUCTION & COSTS COMPANY DATA & RATIOS. koz - FY18 FY19 FY20 FY21 FY22.

Boart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Genex Power (GNX) COMPANY REPORT. NAIF lined up for Stage 2

PRICE $1.16 Regional Express Holdings Ltd REX

Buy Dec 2017 TP (IDR) 57,600 Consensus Price (IDR) 45,545 TP to Consensus Price +26.5% vs. Last Price +20.7%

Noni B (NBL) BUY: FY18e EBITDA +12.8% Key points. Risks and catalysts

Recycling assets at a premium. Vector to sell non-auckland gas assets at a premium. We view the transaction as value accretive

Examples = + = + = = = =

Noni B (NBL) SFH acquisition could be up to 60% EPS accretive. Key points. Risks and catalysts

Freedom Insurance (FIG)

Nanosonics Limited. Australia Health Care Equipment & Supplies. Growth outlook unchanged. Earnings Forecasts. Source Company, LINWAR Research

APN Outdoor Group (APO)

Buy Dec 2018 TP (IDR) 4,770 Consensus Price (IDR) 4,002 TP to Consensus Price +19.2% vs. Last Price +61.1%

ONEVIEW HEALTHCARE PLC

Mayne Pharma (MYX) Yet Another Transformational Acquisition. FY16 Earnings Confirmed. The company did not provide guidance in respect of FY17.

China Renewable Energy Investment Ltd (987_HK)

BUY PLS SHARE PRICE (A$) US$650/T COMPANY DATA & RATIOS. A$m FY18 FY19 FY20 FY21. Source: Blue Ocean estimates

AtCor Medical Holdings Limited (ACG)

Vita Group (VTG) COMPANY REPORT. Vitality in question

High-Tech. Company Data. Data Source: FactSet

Yansab Better than expected results

Result Focus. Pioneer Credit (PNC) Monday, 27 February 2017

SABIC Overall strong performance

BDI BioEnergy Internat Buy

Resetting expectations

DICKER DATA LIMITED ANNUAL RESULTS

Tenaga Nasional New policy underpins rising dividend potential

Hold Dec 2018 TP (IDR) 49,450 Consensus Price (IDR) 52,798 TP to Consensus Price -6.3% vs. Last Price -8.3%

Silver Chef. Capital raising A$7.71 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Itway (ITW.IM) 1H 08/09 results: once again affected by the crisis June 16, 2009

Pacific Energy (PEA)

Crowd Mobile (CM8) A Strong FY17 Result. 24 March Bell Potter Small Cap Team

Buy Dec 2018 TP (IDR) 42,350 Consensus Price (IDR) 36,475 TP to Consensus Price % vs. Last Price %

IOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016.

Buy Dec 2017 TP (IDR) 3,250 Consensus Price (IDR) 3,469 TP to Consensus Price -6.3% vs. Last Price +18.2%

APN Property Group (APD) Buy Share Price: A$0.41

Wisr Ltd. New products to underpin growth

Hold Dec 2018 TP (IDR) 1,850 Consensus Price (IDR) 2,193 TP to Consensus Price -15.6% vs. Last Price +4.5%

MNF Group Limited (MNF)

SeaLink Travel Group (SLK)

Rajesh Exports (RJEX_IN) Earnings Update Report Consumer Discretionary: Gold Jewelry Manufacturer

Waskita Karya (WSKT IJ)

Appen Limited (APX-AU) 29 August 2017

UBS Investment Research Perseus Mining Limited

Eclipx Group. Highlights its funding flexibility A$3.77 AUSTRALIA. Event. Impact. Earnings and target price revision.

Simmtech (222800) Focus on 2H earnings WHAT S THE STORY?

Zain KSA bogged down by high debt

UMW OIL & GAS CORPORATION

SG Fleet Group. Another UK acquisition. Earnings and target price revision

Fisher & Paykel Healthcare

ISRA VISION Neutral

Fisher & Paykel Healthcare

Zain KSA restructuring ensures fresh start

Petro Rabigh Shutdown marred Q2 results

22 February 2018 Ian Munro

Seek. Progresses Zhaopin privatisation A$16.33 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

SG Fleet Group % growth in FY17. Earnings and target price revision. Price catalyst. Catalyst: Results and contract wins.

Vista Group International

Sunway. Another feather to its cap

FY Alliance Aviation Services Limited Results Presentation. August 2018

Premier Investments. Making a move? A$14.18 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Port of Tauranga. Investor Day update. Investor Day focuses on competitive advantages. Forecast revisions; EPS changes are immaterial (Fig 4)

Kangaroo Island Plantation Timbers (KPT) BUY Share Price: A$2.15. NTA uplift buffers project delays Target Price: A$2.71

Platinum Asset Management

Earnings and target price revision. Price catalyst. Catalyst: 1H14 result in February Action and recommendation

Zespri. Vote for change and SunGold licence sales underpin a strong outlook COMPANY RESEARCH. Private Wealth Research

Sims Metal Management

MotorCycle Holdings (MTO) New HOLD: Harley still lacking traction. Key points. Risks and catalysts

Ma aden Equity infusion will strengthen balance sheet

CREDIBLE LABS INC BUY. Partnership Marketing Strategy Paying Off EVENT COMPANY UPDATE HIGHLIGHTS INVESTMENT VIEW. Q4 Activities Report.

Below is the full-list of available criteria in the Lincoln Stock Filter tool:

HOLD Target Price, IDR 1,900 Upside 5.2%

Cochlear. Roberts replaced A$88.66 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Financial Highlights (1)

Osprey (OSP) FY16 EBITDA Loss In Line. OSP has US$21.8m of cash as at 31 December Maintain Buy Rating And Valuation at $0.55

Aventus Retail Property Fund

CogState Limited (CGS)

Transcription:

BUY 0.11 0.39 0.69 SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS

CONTENTS Competitors Products Sales channels Pricing Model

INVESTMENT THESIS

COMPANY OVERVIEW

INDUSTRY OVERVIEW

COMPETITORS BOARD AND MANAGEMENT

BUSINESS MODEL PRODUCTS

SALES CHANNELS PRICING MODEL

FINANCIAL FORECAST

BOEQ Cash Basis Assumptions (A$) 1H16 2H16 FY16 1H17 2H17 FY17 1H18 2H18 FY18 New Customers 19 31 50 39 74 113 120 120 240 Renewing Customers - - - 7 25 32 37 79 116 Total Customers Added in Period 19 31 50 46 99 145 157 199 356 Average annual revenue per customer ($) NMF 12,000 12,000 30,000 30,000 30,000 33,000 33,000 33,000 Assumed % of Annual Upfront Payment 100% 100% 100% 100% 100% 100% 100% 100% Cash Revenue 201,705 254,000 455,705 1,380,000 2,955,000 4,335,000 5,174,400 6,560,400 11,734,800 Operating Costs 2,786,536 2,250,000 5,036,536 2,700,000 2,700,000 5,400,000 3,000,000 3,000,000 6,000,000 Cash EBITDA (2,584,831) (1,996,000) (4,580,831) (1,320,000) 255,000 (1,065,000) 2,174,400 3,560,400 5,734,800 $10 $8 $6 $4 $2 $- 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 Cash Balance Revenue Expenses

BOEQ Accounting Basis Assumptions (A$) 1H16 2H16 FY16 1H17 2H17 FY17 1H18 2H18 FY18 Customers at start of period - 19-50 86 50 150 260 150 Net Customers Added during the period 19 31 50 36 64 100 111 100 211 Total Customers at the end of the period 19 50 50 86 150 150 260 361 361 Average customers over the period 10 35 25 68 118 100 205 310 255 Total Revenue for the period $ 157,566 $ 232,000 $ 389,566 $ 610,000 $ 1,681,250 $ 2,291,250 $ 3,551,350 $ 5,258,275 $ 8,809,625 Average Monthly Revenue Per Customer $ 2,764 $ 1,121 $ 1,299 $ 1,495 $ 2,380 $ 1,914 $ 2,889 $ 2,823 $ 2,878 Annualised Total Revenue run rate at period end $ 600,000 $ 600,000 $ 1,950,000 $ 4,485,000 $ 4,485,000 $ 8,589,900 $ 11,899,800 $ 11,899,800 Monthly Cost base $ 464,423 $ 383,333 $ 423,878 $ 450,000 $ 450,000 $ 450,000 $ 500,000 $ 500,000 $ 500,000 Total Cost base over period $ 2,786,536 $ 2,300,000 $ 5,086,536 $ 2,700,000 $ 2,700,000 $ 5,400,000 $ 3,000,000 $ 3,000,000 $ 6,000,000 Reported EBITDA $ (2,584,831) $ (2,068,000) $ (4,652,831) $ (2,090,000) $ (1,018,750) $ (3,108,750) $ 551,350 $ 2,258,275 $ 2,809,625 BOEQ Forecast (A$M) 1H16 2H16 FY16F 1H17 2H17 FY17F 1H18 2H18 FY18F 1H19 2H19 FY19F 1H20 2H20 FY20F Revenue 0.2 0.3 0.5 0.6 1.7 2.3 3.6 5.3 8.8 7.7 9.6 17.3 13.1 15.3 28.4 Growth rate 287% 562% 403% 482% 213% 284% 116% 83% 96% 71% 59% 64% EBITDA - 2.6-2.0-4.6-2.1-1.0-3.1 0.6 2.3 2.8 4.4 6.3 10.7 9.5 11.7 21.2 Growth rate -21% -49% -33% -126% -322% -190% 690% 181% 281% 118% 85% 98% EBIT -3.00-2.43-5.43-2.51-1.41-3.92 0.14 1.88 2.03 3.95 5.98 9.93 9.10 11.37 20.47 Growth rate 16% 42% 28% -106% -233% -152% 2674% 217% 390% 131% 90% 106% NPAT -2.24-2.38-5.36-2.46-1.38-3.85 0.17 1.93 2.11 4.03 5.23 9.26 6.59 8.26 14.85 Total NPAT Growth -10% 42% 28% -107% -240% -155% 2214% 170% 339% 63% 58% 60% Total Customers at Period End Total 19 50 50 86 150 150 260 361 361 465 585 585 704 817 817 Annualised Revenue Run Rate 0.1 0.1 0.1 0.1 0.4 0.3 0.8 1.0 1.0 1 2 2 2.34 2.72 2.72 Net Operating Cash Flow -2.38-1.95-4.33-1.28 0.29-0.99 2.21 3.61 5.82 6.26 7.52 13.79 9.06 10.54 19.60 Cash Balance at Period End 4.51 4.41 4.41 3.02 3.19 3.19 5.04 8.57 8.57 14.30 21.75 21.75 30.16 40.64 40.64

VALUATION AND RECOMMENDATION

KEY RISKS

SUMMARY FINANCIALS Stock Details Recommendation BUY 52 Week High $1.97 Shares on Issue 106.4m Valuation $0.39 52 Week Low $0.11 Market Capitalisation $11.7m Share price $0.11 Avg Mthly Value $0m Enterprise Value $7.3m Upside/downside 256% Financial Year End 30-June Free Float 50% Profit & Loss ($m) FY16F FY17F FY18F FY19F FY20F Ratio Analysis FY16F FY17F FY18F FY19F FY20F Operating Revenue 0.4 2.3 8.8 17.3 28.4 Revenue Growth 2046.8% 409.7% 284.5% 96.4% 64.4% Other Revenue 0.0 0.0 0.0 0.0 0.0 EBITDA Growth 601.5% 33.0% 190.4% 281.0% 98.5% Total Revenue 0.4 2.3 8.8 17.3 28.4 EBIT Growth 833.7% 27.8% 151.7% 389.9% 106.3% Operating Costs -5.1-5.4-6.0-6.6-7.2 NPAT Growth 1984.4% 28.3% 154.8% 339.1% 60.4% EBITDA -4.6-3.1 2.8 10.7 21.2 D&A -0.8-0.8-0.8-0.8-0.8 EBITDA Margin -1031.4% -135.7% 31.9% 61.9% 74.7% EBIT -5.4-3.9 2.0 9.9 20.5 EBIT Margin -1207.4% -171.1% 23.0% 57.4% 72.0% Net Interest Expense 0.1 0.1 0.1 0.2 0.5 Tax Rate 0.0% 0.0% 0.0% 8.8% 29.3% Pre-Tax Profit -5.4-3.8 2.1 10.2 21.0 NPAT Margin -1193.1% -167.8% 23.9% 53.5% 52.2% Tax Expense 0.0 0.0 0.0-0.9-6.1 Minority Interests 0.0 0.0 0.0 0.0 0.0 Basic EPS ( ) -5.0-3.6 2.0 8.7 14.0 NPAT Reported -5.4-3.8 2.1 9.3 14.9 Diluted EPS ( ) -4.5-3.2 1.8 7.7 12.3 One-Offs after tax 0.0 0.0 0.0 0.0 0.0 Diluted EPS growth 1996% -28% -155% 339% 60% NPAT Normalised -5.4-3.8 2.1 9.3 14.9 0.0 0.0 0.0 0.0 0.0 DPS ( ) 0.0 0.0 0.0 0.0 0.0 Balance Sheet ($m) FY16F FY17F FY18F FY19F FY20F DPS Growth 0.0% 0.0% 0.0% 0.0% 0.0% Cash 4.4 3.2 8.6 21.8 40.6 Franking 0.0 0.0 0.0 0.0 0.0 Inventory 0.0 0.0 0.0 0.0 0.0 Payout Ratio 0.0 0.0 0.0 0.0 0.0 Receivables 0.4 0.2 0.7 1.5 2.4 Other 0.0 0.0 0.0 0.0 0.0 ROE -68% -96% 34% 60% 49% Current Assets 4.9 3.4 9.3 23.2 43.1 ROA (NPAT) -47% -42% 14% 32% 31% PPE 0.1 0.3 0.5 0.8 1.1 ROIC -65% -86% 32% 58% 48% Intangible Assets 3.7 3.0 2.4 2.0 1.6 Other 2.6 2.6 2.6 2.6 2.6 Total Debt 0.0 0.0 0.0 0.0 0.0 Non-Current Assets 6.4 5.9 5.5 5.3 5.3 Net Debt (Cash) -4.4-3.2-8.6-21.8-40.6 Total Assets 11.3 9.2 14.8 28.6 48.3 Current Debt / Total Debt 0% 0% 0% 0% 0% 0.0 0.0 0.0 0.0 0.0 Net Debt / Equity 0% 0% 0% 0% 0% Payables 0.4 0.5 0.5 0.6 0.6 Net Debt/Net Debt + Equity 0% 0% 0% 0% 0% Interest Bearing Liabs 0.0 0.0 0.0 0.0 0.0 EBIT Interest Cover 0.0 0.0 0.0 0.0 0.0 Other 2.3 4.2 6.5 8.6 9.2 Total Debt / EBITDA 0.0 0.0 0.0 0.0 0.0 Current Liabilities 2.7 4.6 7.0 9.2 9.9 Interest Bearing Liabs 0.0 0.0 0.0 0.0 0.0 Capex / Sales 30% 10% 5% 4% 3% Other 0.8 0.8 0.8 0.8 0.8 Capex / Depreciation 50% -214% -206% -191% -177% Non-Current Liabilities 0.8 0.8 0.8 0.8 0.8 Total Liabilties 3.4 5.4 7.8 10.0 10.6 EBITDA -4.6-3.1 2.8 10.7 21.2 0.0 0.0 0.0 0.0 0.0 Change in W/C 0.0-0.3 0.5 0.7 0.9 Contributed Equity 10.7 10.7 10.7 10.7 10.7 Net Interest Expense 0.0 0.0 0.0 0.0 0.0 Reserves + Retained -4.9-8.7-6.6 2.7 17.5 Tax Paid 0.0 0.0 0.0-0.9-6.1 Option Reserve 0.8 0.8 0.8 0.8 0.8 Cash Flow -4.7-3.4 3.3 10.5 16.0 Deferred Consdieration 1.2 1.2 1.2 1.2 1.2 Maintenance Capex -0.1-0.2-0.4-0.6-0.7 Total Equity 7.9 4.0 6.1 15.4 30.2 Free Cash Flow -4.8-3.6 2.9 9.9 15.3 Cashflow Statement ($m) FY16F FY17F FY18F FY19F FY20F Valuation FY16F FY17F FY18F FY19F FY20F Gross Cash Flow -4.4-1.1 5.7 14.5 25.2 Shares on Issue (Million) 106.4 106.4 106.4 106.4 106.4 Net Interest 0.1 0.1 0.1 0.2 0.5 Normalised EPS ( ) -5.0-3.6 2.0 8.7 14.0 Tax Paid 0.0 0.0 0.0-0.9-6.1 PE -2.2x -3.0x 5.5x 1.3x 0.8x Other 0.0 0.0 0.0 0.0 0.0 CFPS ( ) -4.4-3.2 3.1 9.9 15.0 Net Operating Cash Flows -4.3-1.0 5.8 13.8 19.6 P/CFPS -2.5-3.4 3.5 1.1 0.7 0.0 0.0 0.0 0.0 0.0 FCFPS -4.5-3.4 2.7 9.3 14.4 Payments for PPE -0.1-0.2-0.4-0.6-0.7 P/FCF -2.4-3.2 4.1 1.2 0.8 Payments for Acquisitions 0.0 0.0 0.0 0.0 0.0 Other -0.4 0.0 0.0 0.0 0.0 DPS ( ) 0.0 0.0 0.0 0.0 0.0 Net Investing Cash Flows -0.4-0.2-0.4-0.6-0.7 Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0 0.0 0.0 0.0 0.0 Net Share Issues 9.1 0.0 0.0 0.0 0.0 BVPS ($) Net Borrowings 0.0 0.0 0.0 0.0 0.0 P/BV Dividends Paid 0.0 0.0 0.0 0.0 0.0 NTAPS ($) Other 0.0 0.0 0.0 0.0 0.0 P/NTA Net Financing Cash Flows 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EV/EBITDA -1.6x -2.3x 2.6x 0.7x 0.3x Change in Cash Held 4.4-1.2 5.4 13.2 18.9 EV/EBIT -1.3x -1.9x 3.6x 0.7x 0.4x Cash at Beginning of Period 0.0 4.4 3.2 8.6 21.8 Adjustments 0.0 0.0 0.0 0.0 0.0 PE Ratio (Valuation) -7.8x -10.8x 19.8x 4.5x 2.8x Cash at End of Period 4.4 3.2 8.6 21.8 40.6 EV/EBITDA (Valuation) -1.0x -1.0x 3.1x 2.0x 1.9x

ANALYST CONTACTS AUTHORITY CONTACTS HEAD OFFICE DISCLAIMER This document is a private communication to clients and is not intended for public circulation or for the use of any third party, without the prior approval of Blue Ocean Equities Pty Limited. This is general investment advice for Institutional and Sophisticated Investors only and does not constitute personal advice to any person. Because this document has been prepared without consideration of any specific client s financial situation, particular needs and investment objectives you should consult your own investment adviser before any investment decision is made on the basis of this document. While this document is based on information from sources which are considered reliable, Blue Ocean Equities Pty Limited has not verified independently the information contained in the document and Blue Ocean Equities Limited and its directors, employees and consultants do not represent, warrant or guarantee, expressly or by implication, that the information contained in this document is complete or accurate. Nor does Blue Ocean Equities Limited accept any responsibility for updating any advice, views opinions, or recommendations contained in this document or for correcting any error or omission which may become apparent after the document has been issued. Except insofar as liability under any statute cannot be excluded. Blue Ocean Equities Pty Limited and its directors, employees and consultants do not accept any liability (whether arising in contract, in tort or negligence or otherwise) for any error or omission in this document or for any resulting loss or damage (whether direct, indirect, consequential or otherwise) suffered by the recipient of this document or any other person. DISCLOSURE Blue Ocean Equities Pty Limited, its employees, consultants and its associates within the meaning of Chapter 7 of the Corporations Law may receive commissions, underwriting and management fees from transactions involving securities referred to in this document, and may from time to time hold interests in the securities referred to in this document. Blue Ocean Equities Pty Limited and associates hold 1,283,571shares in RFN at the date of this report and this position may change at any time without notice.